These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18887904)

  • 21. [Results obtained with the use of chlorambucil in the treatment of malignant lymphopathies].
    RABENKO J
    Sem Med; 1961 Jul; 119():378-80. PubMed ID: 14489588
    [No Abstract]   [Full Text] [Related]  

  • 22. Nitrogen mustards in the management of Hodgkin's disease and the leukemias. VII. Clinical reports, 1959-62.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1962 Oct; 134():374-88. PubMed ID: 13976141
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of human leukemias and Hodgkin's disease with Dopan (uracil mustard).
    SAMPEY JR
    J S C Med Assoc; 1962 May; 58():175-6. PubMed ID: 14496660
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of nitrogen mustard therapy in the treatment of lymphomas and leukemias.
    SPURR CL; SMITH TR; BLOCK M; JACOBSON LO
    Am J Med; 1950 Jun; 8(6):710-23. PubMed ID: 15419186
    [No Abstract]   [Full Text] [Related]  

  • 25. Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M. Wintrobe, William Dameshek, Morton J. Goodman, Alfred Gilman and Margaret T. McLennan.
    Goodman LS; Wintrobe MM; Dameshek W; Goodman MJ; Gilman A; McLennan MT
    JAMA; 1984 May; 251(17):2255-61. PubMed ID: 6368885
    [No Abstract]   [Full Text] [Related]  

  • 26. Nitrogen mustards in the management of Hodgkin's disease and the leukemias. IX. Further clinical reports, 1960-1962.
    SAMPEY JR
    J S C Med Assoc; 1963 Aug; 59():272-4. PubMed ID: 13976136
    [No Abstract]   [Full Text] [Related]  

  • 27. [Nitrogen mustards; Treatment of hodgkin's disease and related conditions].
    DE LANDSHEERE B; OTTE P
    Belg Tijdschr Geneesk; 1948 Oct; 4(19):886-97. PubMed ID: 18122322
    [No Abstract]   [Full Text] [Related]  

  • 28. [The treatment of lymphogranulomatosis with nitrogen mustard gas].
    ANDERSEN BJ; BRØCHNER-MORTENSEN K
    Nord Med; 1948 Jan; 37(2):87. PubMed ID: 18857350
    [No Abstract]   [Full Text] [Related]  

  • 29. Radiation treatment of leukemias, Hodgkin's disease and lymphosarcoma.
    PEAKE JD; ESKRIDGE M
    Miss Valley Med J; 1951 Nov; 73(6):189-92. PubMed ID: 14882241
    [No Abstract]   [Full Text] [Related]  

  • 30. [Naphthyl-chloroethylamine therapy of Hodgkin's disease and allied forms].
    BARENGHI G
    Accad Medica; 1950 Dec; 65(12):506-27. PubMed ID: 14856512
    [No Abstract]   [Full Text] [Related]  

  • 31. [Six cases of Paltauf-Sternberg lymphogranulomatosis and two analogous conditions treated with nitrogen mustard, a derivative of hyperperitis].
    DE LANDSHEERE B; OTTO P
    Scalpel (Brux); 1948 Sep; 101(36):862. PubMed ID: 18933026
    [No Abstract]   [Full Text] [Related]  

  • 32. [Six cases of Paltauf-Sternberg lymphogranulomatosis and two analogous conditions treated by nitrogen mustard, a derivative of mustarditis].
    DE LANDSHEERE B; COTTE P
    Brux Med; 1948 Aug; 28(32):1644. PubMed ID: 18883005
    [No Abstract]   [Full Text] [Related]  

  • 33. CLINICAL EVALUATION OF URACIL MUSTARD.
    WILLIAMS HM
    Cancer Chemother Rep; 1963 Oct; 32():73-6. PubMed ID: 14088838
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of malignant lymphomas and lymphadenoses with leukeran.
    LIBANSKY J; CHUDOMEL V; BRABEC V; SOCHMAN J
    Neoplasma; 1959; 6():415-24. PubMed ID: 14416684
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid].
    BERNARD J; MATHE G; WEIL M
    Sang; 1957; 28(1):80-2. PubMed ID: 13432604
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trial of a new nitrogen-mustard compound.
    SELLEI C; ECKHARDT S; HARTAI F; DUMBOVICH B
    Lancet; 1956 May; 270(6926):785-6. PubMed ID: 13320884
    [No Abstract]   [Full Text] [Related]  

  • 37. THE LOCAL INFLAMMATORY RESPONSE IN PATIENTS WITH BLOOD DYSCRASIAS AS TESTED BY THE SKIN WINDOW TECHNIQUE.
    WEBER RE; HELMAN N
    Bull Sinai Hosp Detroit; 1963; 11():95-9. PubMed ID: 14064458
    [No Abstract]   [Full Text] [Related]  

  • 38. LONG TERM RESULTS ACHIEVED WITH THE USE OF ALKYLATING AGENTS IN MALIGNANT LYMPHOMA AND HODGKIN'S DISEASE.
    PAPAC RJ; WOOD DA
    Acta Unio Int Contra Cancrum; 1964; 20():377-9. PubMed ID: 14151934
    [No Abstract]   [Full Text] [Related]  

  • 39. THE MANAGEMENT OF LEUKEMIA AND LYMPHOMA.
    HUTCHISON JL
    Appl Ther; 1964 Jul; 6():591-2. PubMed ID: 14179434
    [No Abstract]   [Full Text] [Related]  

  • 40. [Nitrogen mustard therapy of malignant tumors].
    LINDEMANN M; GUMMEL H
    Dtsch Gesundheitsw; 1950 Nov; 5(48):1506-15. PubMed ID: 14793092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.